Mobile App Education Based on Orem's Self-Care Model in Multiple Myeloma Patients (OCARE-MM)

Ozlem

Status: Active, not recruiting

Conditions: Self-care; Quality of Life; Multiple Myeloma (MM)

Treatments: Behavioral: Mobile App Education

Study type: Interventional

Funder types: Other

Identifiers

NCT07088783

DEU-MM-RCT-2024-0923

2024/09-23 (Other Identifier)

TDK-2025-3605 (Other Identifier)

Details and patient eligibility

About

This randomized controlled trial aims to assess the effectiveness of a mobile application-based education program, developed according to Orem's Self-Care Model, in improving self-care agency and quality of life among patients with multiple myeloma in Turkey. Participants are recruited from the outpatient clinic of a hospital and randomly assigned to either the intervention or control group. The intervention group uses the mobile application for 24 weeks, while the control group continues with routine care and receives a standard one-page brochure commonly distributed to cancer patients. All participants complete a demographic form, the EORTC QLQ-C30, QLQ-MY20, and the Self-Care Agency Scale at baseline, week 12, and week 24. The collected data will be used to compare changes in self-care agency and quality of life between the two groups over time.

Full description

This study was conducted to address the self-care needs of patients diagnosed with multiple myeloma, a chronic and complex hematologic cancer. Based on Orem's Self-Care Deficit Nursing Theory, a mobile application was developed to improve patients' self-care agency and quality of life. The intervention group uses the mobile application for 24 weeks, which includes educational content, self-monitoring features, and motivational messages. The control group receives routine care, which includes standard medical follow-up and a one-page general information brochure commonly provided to cancer patients at the hospital. Self-care agency and quality of life are assessed using the Self-Care Agency Scale, EORTC QLQ-C30, and EORTC QLQ-MY20 at three time points: baseline, week 12, and week 24. The results are expected to contribute to evidence-based self-care interventions for patients with hematologic malignancies.

Enrollment: 60 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosed with multiple myeloma and received at least one course of treatment
• Age 18 or older
• Able to speak and read Turkish
• ECOG performance status of I, II, or III
• Has used at least one Android-based digital tool (e.g., sending text messages, email, using mobile apps)
• Literate (able to read and write)
• Willing to participate and able to provide written informed consent

Exclusion criteria

• Not currently diagnosed with multiple myeloma
• Has cognitive or psychological disorders that prevent completing questionnaires or using the mobile application
• Unable to speak or understand Turkish
• Unwilling or unable to provide written informed consent

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

60 participants in 2 patient groups

Intervention Group

Experimental group

Description:

A mobile application was provided to support self-care and quality of life, based on Orem's Self-Care Deficit Model. Patients were asked to use it regularly for 24 weeks.

Treatment:

Behavioral: Mobile App Education

Control Group

No Intervention group

Description:

Participants received routine care and a one-page standard information brochure for cancer patients.